Semaglutide Recall: Boothwyn Pharmacy 2.5 mg/mL injection
Announced 2025-09-10 · FDA
FDA is recalling Boothwyn Pharmacy LLC's Semaglutide, 2.5 mg/mL injection (4 mL vials) because the drug is subpotent. Approximately 648 vials were distributed nationwide. The recall numbers are 03202025@2, 03202025@3, and 03202025@4 with a BUD of 07/18/2025.
| Brand | Boothwyn Pharmacy LLC |
|---|---|
| Product | Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy |
| Reason | Subpotent Drug |
| Severity | moderate |
| Units affected | 186 |
| Distribution | U.S. Nationwide |
| Agency | FDA |
| Recall / campaign no. | 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025 |
WHAT YOU SHOULD DO
- Do not use any recalled injections.
- If you have any of the affected vials, contact Boothwyn Pharmacy LLC to arrange return, disposal, or replacement, and keep packaging with the recall numbers 03202025@2, 03202025@3, or 03202025@4 and the BUD date 07/18/2025.
- If you have used the product, discuss potential risks with your healthcare provider and report any adverse effects to the FDA MedWatch program.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.